Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Haynes: Centralized Envelope Phase I Study |
| Strategy: | Combo: DNA & vector vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2012-04-30 |
| Study Made Public: | 2014-01-24 |
Title
Haynes_Immunogenicity in NHP Study
Description
CAVD 363 (NHP#45) is a non-human primate study to evaluate and compare the immunogenicity of Clade B, CON-S, and Mosaic Env DNA and NYVAC prime/boost regimens.
Sign in to see full information about this study and to download study data.
Products
DNA-B-Env DNA Mosaic Env DNA-Con S-Env NYVAC-Con S-Env NYVAC-Mosaic-Env NYVAC-B-EnvIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.